Compare SGBX & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGBX | PMN |
|---|---|---|
| Founded | 2007 | 2004 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Pharmaceuticals and Biotechnology |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.0M | 23.5M |
| IPO Year | 2017 | N/A |
| Metric | SGBX | PMN |
|---|---|---|
| Price | $1.96 | $8.48 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $72.67 |
| AVG Volume (30 Days) | ★ 1.1M | 22.9K |
| Earning Date | 11-14-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,382,896.00 | N/A |
| Revenue This Year | $1,628.82 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.81 | $6.27 |
| 52 Week High | $122.88 | $39.75 |
| Indicator | SGBX | PMN |
|---|---|---|
| Relative Strength Index (RSI) | 39.20 | 66.18 |
| Support Level | $1.83 | $6.62 |
| Resistance Level | $2.22 | $8.59 |
| Average True Range (ATR) | 0.22 | 0.58 |
| MACD | -0.03 | -0.24 |
| Stochastic Oscillator | 15.22 | 69.76 |
Safe & Green Holdings Corp is a modular solutions company. The company currently provides modules made out of both code-engineered cargo shipping containers and wood for use as both permanent or temporary structures for residential housing use and commercial use, including for health care facilities. It operates in four segments: construction services; medical; real estate development; and environmental. The company generates the majority of its revenue from the Construction segment includes the company's manufacturing unit SG ECHO and other modules projects.
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.